We are live on ! Find out more
SPXV icon

ProShares S&P 500 ex-Health Care ETF

13 hedge funds and large institutions have $14.5M invested in ProShares S&P 500 ex-Health Care ETF in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $13.3M → $14.5M (+$1.19M)

8% more funds holding

Funds holding: 1213 (+1)

4.21% less ownership

Funds ownership: 156.3%152.09% (-4.2%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

SPXV Hedge Fund Activity: Q4 2023 in Review

13 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ProShares S&P 500 ex-Health Care ETF (SPXV) for Q4 2023, worth a combined $14.5M — up 8.9% from $13.3M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SPXV positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Central Trust Company, opening a new position worth an estimated $29.2K. The largest seller was JP Morgan Chase, cutting an estimated $149K.

  • 13 institutional investors held ProShares S&P 500 ex-Health Care ETF (SPXV) as of Q4 2023, up from 12 in Q3 2023.
  • Funds reported $14.5M of ProShares S&P 500 ex-Health Care ETF stock for Q4 2023, up 8.9% quarter-over-quarter.
  • 1 fund opened new ProShares S&P 500 ex-Health Care ETF positions in Q4 2023 and 0 closed out, a net change of +1 holder.
  • The largest ProShares S&P 500 ex-Health Care ETF buyer in Q4 2023 was Central Trust Company, an estimated $29.2K added.
  • The largest ProShares S&P 500 ex-Health Care ETF seller in Q4 2023 was JP Morgan Chase, an estimated $149K sold.

Based on aggregated 13F filings for Q4 2023.